antiarrhythmic

Also found in: Thesaurus, Medical, Encyclopedia.

an·ti·ar·rhyth·mic

(ăn′tē-ə-rĭth′mĭk, ăn′tī-)

adj.

Preventing or alleviating irregularities in the force or rhythm of the heart.

An antiarrhythmic drug.

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

antiarrhythmic

(ˌæntɪeɪˈrɪðmɪk)

(Pharmacology) a drug that corrects irregular heartbeat

adj

(Pharmacology) pertaining to drugs that correct irregular heartbeat

Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

ThesaurusAntonymsRelated WordsSynonymsLegend:

Switch to new thesaurus

Noun

antiarrhythmic - a drug used to treat an abnormal heart rhythm

antiarrhythmic drug, antiarrhythmic medication

amiodarone, Cordarone - an antiarrhythmic drug (trade name Cordarone) that has potentially fatal side effects and is used to control serious heart rhythm problems only when safer agents have been ineffective

encainide, Enkaid - antiarrhythmic drug (trade name Enkaid) used to treat life-threatening arrhythmias but increases the risk of sudden death in heart attack patients

flecainide, Tambocor - oral antiarrhythmic medication (trade name Tambocor) used as a last resort in treating arrhythmias; increases the risk of sudden death in heart attack patients

medicament, medication, medicinal drug, medicine - (medicine) something that treats or prevents or alleviates the symptoms of disease

mexiletine, Mexitil - antiarrhythmic drug (trade name Mexitil) used to treat ventricular arrhythmias

Quinidex, quinidine, Quinora - cardiac drug (trade names Quinidex and Quinora) used to treat certain heart arrhythmias

tocainide, Tonocard - antiarrhythmic drug (trade name Tonocard) used to treat ventricular arrhythmias when less dangerous drugs have failed

Translations

antiarrhythmic

adj & n antiarrítmico

References in periodicals archive ?

(NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that an abstract highlighting the results of the SPECTRUM study evaluating Brinavess(vernakalant hydrochloride, IV), the Company's antiarrhythmic drug for the rapid conversion of recent onset atrial fibrillation (AF), was selected for a poster presentation at the European Society of Cardiology (ESC) 2019 Congress taking place August 31 - September 4, 2019, in Paris.

Correvio Announces BRINAVESS Spectrum Data to be presented at the European Society of Cardiology 2019 Congress

In collaboration with members of the UCLA Cardiovascular Research Laboratory (CVRL), Numerate will use the funds to support the discovery of novel, small molecule drug candidates that address the need for a well-tolerated antiarrhythmic therapy for the treatment and prevention of ventricular tachycardias and fibrillation (VT/VF).

Numerate wins USD2m SBIR Phase II grant

The results from a 10-year randomized trial known as the CABANA trial (Catheter Ablation versus Antiarrhythmic Drug trial for Atrial Fibrillation) have recently been released.

Treatment Insights for A-fib: A recently completed large trial compares catheter ablation to drug-only therapy for this common heart rhythm disorder

According to the company, Brinavess (vernakalant HCl, IV) is an antiarrhythmic drug that acts preferentially in the atria by prolonging atrial refractoriness and slowing impulse conduction in a rate-dependent fashion.

Correvio resubmits Vernakalant NDA to US FDA for recent onset atrial fibrillation

This poster presentation highlights reduced hospitalization in patients treated with Brinavess, Correvio's antiarrhythmic drug for the rapid conversion of recent onset atrial fibrillation, from a clinical survey assessing patients with acute AF at the Hillel Yaffe Medical Center located in Hadera, Israel.

Correvio announces presentation of new Brinavess data

Bretylium Tosylate Injection is indicated for the prophylaxis and therapy of ventricular fibrillation; treatment of life-threatening ventricular arrhythmia that has failed to respond to first-line antiarrhythmic agents.

Pii to develop FDA-approved drug product

Due to the fact that antiarrhythmic medications are associated with the adverse effects of proarrhythmic or refractory hypotension, the use of these agents may further deteriorate the condition of patients with tachyarrhythmias.

Extracorporeal Membrane Oxygenation Support for Incessant Tachyarrhythmia-Induced Severe Cardiogenic Shock

(9) Women and patients treated with antiarrhythmic drugs were also at higher risk of AF after ablation.

Frequency of atrial arrhythmias after atrial flutter ablation and the effect of presenting rhythm on the day of ablation

Continued treatment with an antiarrhythmic drug in the drug-arm patients, compared with no drug treatment in the ablated patients, "is absolutely the explanation" for the observed difference in quality of life, she said.

AF ablation topped drugs for improving quality of life

Electrophysiologists from the US provide 21 chapters on anatomy in clinical electrophysiology, membrane and cellular electrophysiology, mechanisms of tachycardias, the basic electrophysiology study, basic principles in clinical electrophysiology, and various disorders, as well as pacemaker and implantable cardioverter defibrillator (ICD) indications, function, and troubleshooting; noninvasive diagnostic testing; and antiarrhythmic drugs.

Practical Clinical Electrophysiology, 2nd Edition (online access included)

In these conditions, patients undergoing antiarrhythmic therapy with drugs known to prolong the QT interval pose a real diagnostic challenge.